J&J’s type 2 diabetes drug INVOKANA significantly reduces major heart complications in CANVAS program

Singapore – Results from the landmark CANVAS Program showed INVOKANA (canagliflozin) significantly reduc...

June 27, 2017 | Tuesday | News
BioAuxilium completes development of its 100th TR-FRET assay kit

Canada based company BioAuxilium specialised in the development of custom TR-FRET assay kit recently announced the succe...

June 23, 2017 | Friday | News
Major advancement in cell-based influenza vaccine technology by Seqirus

Innovator in influenza vaccines and pandemic preparedness Seqirus recently announced the next major advancement in the u...

June 23, 2017 | Friday | News
New patent issuance for Zyga's SImmetry Sacroiliac Joint Fusion System

Singapore - Zyga Technology, Inc., a US based medical device company announced the issuance of a new US Patent represent...

June 22, 2017 | Thursday | News
New antibody for effective blood cancer treatment using two-pronged approach

Singapore- Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells direct...

June 22, 2017 | Thursday | News
Sunless tan now a reality!

Scientists have answered the woes of spending hours and hours on sunbeds to achieve the perfect bronzed tone. Better yet...

June 21, 2017 | Wednesday | News
A type-2 diabetes drug found to reduce heart and kidney risk

Researchers have claimed that a drug that lowers blood sugar levels for people with Type 2 diabetes may also significant...

June 21, 2017 | Wednesday | News
Enzychem Lifesciences Announces Global Phase 2 Trial Inititation of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)

Enzychem Lifesciences, Corp., a Korea based life sciences company announced the initiation of the dose-escalation stage ...

June 20, 2017 | Tuesday | News
NanoBio And Porton Biopharma receive approval to advance Anthrax Vaccine

NanoBio Corporation, a US based biopharmaceutical company focused on developing and commercializing vaccines and anti-in...

June 20, 2017 | Tuesday | News
New, long-acting insulin therapy demonstrates Cardiovascular Safety

Singapore - During a symposium, titled "Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with ...

June 13, 2017 | Tuesday | News
A translational research collaboration

The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) announced a strategic collaboration to acc...

June 9, 2017 | Friday | News
BD Receives FDA 510(K) Clearance for Molecular Test of Acute Gastroenteritis.

Singapore - BD (Becton, Dickinson and Company), a global medical technology company, announced 510 (k) clearance from th...

June 5, 2017 | Monday | News
Trends in Drug Discovery Outsourcing: A Perspective

Dr Subir Basak Chief Business Officer, GVK Biosciences Over the last two decades, the Pharmaceutical industry has seen ...

June 2, 2017 | Friday | Analysis
FDA approves new Novo Nordisk treatment for patients with Hemophilia

Singapore - Novo Nordisk, a US based global healthcare company announced that the U.S. Food and Drug Administration (FDA...

June 1, 2017 | Thursday | News
Biogen acquires Remedy Pharmaceuticals’ late stage drug CIRARA

Singapore: Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to...

May 23, 2017 | Tuesday | News
Symic Bio Secures $30 Million Series B financing 

Singapore: Symic Bio, a US based biopharmaceutical company announced the successful completion of a $30 million&nbs...

May 23, 2017 | Tuesday | News
Sanofi enters into a $273 mn research deal with Exscientia

Singapore: French drug giant Sanofi has inked a $273 million research deal and licence option agreement in metabolic dis...

May 10, 2017 | Wednesday | News
FDA approves first new drug for ALS in 2 decades

After nearly two decades FDA has finally approved a drug for the treatment of amyotrophic lateral sclerosis (ALS). The d...

May 11, 2017 | Thursday | News